- Home
- LOVE vs LXEO Comparison
LOVE vs LXEO Comparison
Compare LOVE & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOVE
- LXEO
- Stock Information
- Founded
- LOVE 1998
- LXEO 2017
- Country
- LOVE United States
- LXEO United States
- Employees
- LOVE N/A
- LXEO N/A
- Industry
- LOVE Other Specialty Stores
- LXEO
- Sector
- LOVE Consumer Discretionary
- LXEO
- Exchange
- LOVE Nasdaq
- LXEO Nasdaq
- Market Cap
- LOVE 280.7M
- LXEO 290.5M
- IPO Year
- LOVE 2018
- LXEO 2023
- Fundamental
- Price
- LOVE $18.08
- LXEO $5.36
- Analyst Decision
- LOVE Strong Buy
- LXEO Strong Buy
- Analyst Count
- LOVE 5
- LXEO 7
- Target Price
- LOVE $30.00
- LXEO $15.29
- AVG Volume (30 Days)
- LOVE 488.2K
- LXEO 421.5K
- Earning Date
- LOVE 09-11-2025
- LXEO 11-12-2025
- Dividend Yield
- LOVE N/A
- LXEO N/A
- EPS Growth
- LOVE 33.72
- LXEO N/A
- EPS
- LOVE 0.79
- LXEO N/A
- Revenue
- LOVE $690,298,000.00
- LXEO N/A
- Revenue This Year
- LOVE $6.72
- LXEO N/A
- Revenue Next Year
- LOVE $7.18
- LXEO N/A
- P/E Ratio
- LOVE $22.84
- LXEO N/A
- Revenue Growth
- LOVE N/A
- LXEO N/A
- 52 Week Low
- LOVE $12.12
- LXEO $1.45
- 52 Week High
- LOVE $39.49
- LXEO $11.72
- Technical
- Relative Strength Index (RSI)
- LOVE 45.97
- LXEO 64.62
- Support Level
- LOVE $17.51
- LXEO $4.90
- Resistance Level
- LOVE $18.24
- LXEO $5.56
- Average True Range (ATR)
- LOVE 0.96
- LXEO 0.30
- MACD
- LOVE -0.17
- LXEO 0.02
- Stochastic Oscillator
- LOVE 33.96
- LXEO 78.26
About LOVE The Lovesac Company
The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.